Naaval Nei (Internal) for Kudal Kirumi (Ascariasis)

Phase II Non-Randomized clinical study on Kudal Kirumi (Naaga Puchi Noi)-Ascariasis with the evaluation of siddha trial drug Naaval Nei in children. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/086007

Enrollment

Registered

2025-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B779- Ascariasis, unspecified

Interventions

Intervention1: Naaval Nei (Internal): Naaval Nei 2 to 4 ml once a day for 5 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Loss of appetite, Pain around umbilicus, Presence of perianal itching, History of passing worms in the stools, Teeth grinding during sleep (Bruxism).

Exclusion criteria

Exclusion criteria: Enteric fever, Amoebiasis, Severe dehydration, Severe anemia (Hemoglobin less than 7 gm/dl)

Design outcomes

Primary

Measure	Time frame
The outcome will be assessed by absence of ova, cyst in motion investigations and symptoms reduced completely, increased hemoglobin level, decreased ESR and eosinophil count.Timepoint: 5 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Thanusha V

Government Siddha Medical College, Arumbakkam, Chennai

drsatheeshkumarsiddha@gmail.com9962066694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026